(19)
(11) EP 2 089 012 A2

(12)

(88) Date of publication A3:
10.07.2008

(43) Date of publication:
19.08.2009 Bulletin 2009/34

(21) Application number: 07864234.5

(22) Date of filing: 09.11.2007
(51) International Patent Classification (IPC): 
A61K 31/165(2006.01)
A61P 19/02(2006.01)
C07C 237/22(2006.01)
(86) International application number:
PCT/US2007/084314
(87) International publication number:
WO 2008/058278 (15.05.2008 Gazette 2008/20)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 09.11.2006 US 857779 P
09.11.2006 US 857794 P
09.11.2006 US 857791 P
09.11.2006 US 857790 P
09.11.2006 US 857781 P
09.11.2006 US 857780 P
09.11.2006 US 857793 P
09.11.2006 US 857792 P

(71) Applicant: Wyeth
Madison, NJ 07940 (US)

(72) Inventors:
  • LIANG, Jennifer Q.
    Morris Plains, NJ 07950 (US)
  • WANG, Qiuxia Trisha
    Nanuet, NY 10954 (US)
  • KU, Mann-ching Sherry
    Thiells, NY 10984 (US)
  • MICHALAK, Ronald S.
    Congers, NY 10920 (US)
  • HUANG, W. James
    Hillsborough, NJ 08844 (US)

(74) Representative: Talbott, Dawn Jacqueline 
Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow
Maidenhead, Berkshire SL6 0PH
Maidenhead, Berkshire SL6 0PH (GB)

   


(54) POLYMORPHS OF N²-(1,1'- BIPHENYL- 4-YLCARBONYL)-N¹-[2-(4-FLUOROPHENYL)-1,1-DIMETHYLETHYL]-L-ALPHA -GLUTAMINE